Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LLY
LLY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LLY News
Eli Lilly Expands Coverage for Obesity Medications
1d ago
PRnewswire
Eli Lilly's Market Cap Surpasses $1 Trillion Again
17h ago
Yahoo Finance
Eli Lilly Shares Surge After CVS Restores Zepbound and Adds Foundayo
1d ago
Yahoo Finance
U.S. Stocks Reach Record Highs as Investor Optimism Grows
1d ago
stocktwits
Foundayo Outperforms Competitors in Type 2 Diabetes Treatment
1d ago
PRnewswire
Eli Lilly Unveils Phase 3 Data for Foundayo and Retatrutide at ADA 2026
1d ago
Newsfilter
CVS Restores Coverage for Eli Lilly's Weight Loss Drug
1d ago
stocktwits
Intense Pharmaceutical Rivalry: Novo Nordisk vs. Eli Lilly in GLP-1 Market
1d ago
Fool
Competitive Analysis of Novo Nordisk and Eli Lilly
1d ago
NASDAQ.COM
Stocks Edge Up as Snowflake Surges 35% on Strong Earnings
1d ago
CNBC
France Becomes First EU Nation to Reimburse Weight Loss Medications
1d ago
seekingalpha
Small Biotech Firms Rapidly Adopt AI for Efficiency
1d ago
Newsfilter
CVS Restores Coverage for Eli Lilly's Weight Loss Drug
1d ago
seekingalpha
CVS Reintroduces Eli Lilly's Zepbound to Drug Lists
1d ago
Newsfilter
CVS Restores Coverage for Eli Lilly's Weight Loss Drug Zepbound
1d ago
CNBC
Truist Initiates Coverage on VKTX with Buy Rating and $83 Price Target
1d ago
stocktwits
Show More News
